Home

PB Ratio of Accretion Pharmaceuticals Ltd

Image

Accretion Pharmaceuticals Ltd

NSE: AccretionPha.

PB Ratio

2.2

Last updated on: May 23, 2025

Key Highlights

  • The latest PB Ratio of Accretion Pharmaceuticals Ltd is 2.2.
  • The PB ratio of the Accretion Pharmaceuticals Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The latest PB Ratio of Accretion Pharmaceuticals Ltd is 0.
  • The PB ratio of the Accretion Pharmaceuticals Ltd is below 1 which indicates that the stock is undervalued.
Image

Accretion Pharmaceuticals Ltd

NSE: AccretionPha.

PB Ratio

-

Last updated on: Invalid Date

Company Fundamentals for Accretion Pharmaceuticals Ltd

Market Price of Accretion Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Accretion Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
23 May 202574.9
22 May 202578.8
21 May 202582.95

SWOT Analysis

Strength

0

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Accretion Pharmaceuticals Ltd

Asset Value vs Market Value of Accretion Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Key Valuation Metric of Accretion Pharmaceuticals Ltd

X

Historical Market Cap of Accretion Pharmaceuticals Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Accretion Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Accretion Pharmaceuticals Ltd News Hub

NSE SME Accretion Pharmaceuticals' IPO ends with subscription of 7.31 times

The initial public offer (IPO) of Accretion Pharmaceuticals received bids for 2,00,06,400 shares as

Read more

19 May 25

NSE SME Accretion Pharma stumbles on market debut

The scrip was listed at 79, a discount of 21.78% over the initial public offer (IPO) price. The stoc

Read more

21 May 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of null

What is the PB ratio of Accretion Pharmaceuticals Ltd?

The current PB ratio of Accretion Pharmaceuticals Ltd is 0.0. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Accretion Pharmaceuticals Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Accretion Pharmaceuticals Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Accretion Pharmaceuticals Ltd calculated?

The PB ratio of Accretion Pharmaceuticals Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Accretion Pharmaceuticals Ltd?

A high PB ratio suggests that Accretion Pharmaceuticals Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Accretion Pharmaceuticals Ltd?

A low PB ratio of Accretion Pharmaceuticals Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Accretion Pharmaceuticals Ltd PB Ratio change over time?

Yes, the PB ratio of Accretion Pharmaceuticals Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions